BioCurex, Inc.(fka BOCX)

[bocxman]

This line from the research report is news to me:
"In collaboration with the Center for Cancer Care in Goshen, Indiana, BioCurex is developing an AFP based ligand to attach a radioisotope for the imaging of breast tumors in a nuclear medicine technique called mammoscinitgraphy."

The Goshen press release did not get into this kind of detail did it? I reported that based on my talk with Dr. Schwartzentruber at Goshen, my impression was they were doing 100% imaging despite the fact that the P.R says diagnostics and imaging -- but this looks like a much more focused and detailed plan that what has been said up until now.